From today, a group of patients with breast and lung cancer will be the first to be able to receive taxpayer-funded medicine in private clinics. Pharmac's manager in charge of pharmaceutical funding, Claire Pouwels spoke to Corin Dann.
From today, a group of patients with breast and lung cancer will be the first to be able to receive taxpayer-funded medicine in private clinics. Pharmac's manager in charge of pharmaceutical funding, Claire Pouwels spoke to Corin Dann.